United States v. Konieczka

30 M.J. 752, 1990 WL 35788
CourtU.S. Army Court of Military Review
DecidedMarch 26, 1990
DocketACMR 9000001
StatusPublished
Cited by2 cases

This text of 30 M.J. 752 (United States v. Konieczka) is published on Counsel Stack Legal Research, covering U.S. Army Court of Military Review primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Konieczka, 30 M.J. 752, 1990 WL 35788 (usarmymilrev 1990).

Opinion

OPINION OP THE COURT

NEURAUTER, Judge:

Pursuant to Article 62, Uniform Code of Military Justice, 10 U.S.C. § 862 (Supp. II 1984) [hereinafter UCMJ], and Manual for Courts-Martial, United States, 1984, Rule for Courts-Martial [hereinafter R.C.M.] 908(b) the government appeals a ruling by the military judge in this case suppressing the results of a urinalysis test which implicate appellee. These test results are essential evidence with respect to the Specification and Charge alleging wrongful use of marijuana in violation of Article 112a, UCMJ, 10 U.S.C. § 912a.

I

Appellee submitted a urine sample as part of a unit urinalysis inspection on 17 April 1989. The samples, including appellee’s, were forwarded to Mr. Christman, the Fort Lee Alcohol and Drug Control Officer, for prescreening to determine if any of the samples contained evidence of illegal drug use. Once the prescreening was completed, Mr. Christman randomly selected several samples that had tested negative for drugs. He also selected two other samples, including appellee’s, which indicated the presence of the marijuana metabolite 11-nor-delta 9-tetrahydrocan-nabinol-9-carboxylic acid (THC), but which fell short of the level required to be identified as a positive sample (100 nanograms per milliliter). Mr. Christman then forwarded those selected samples to the drug testing laboratory at Fort Meade for further testing. Appellee’s urine was tested at Fort Meade and determined to be positive for the presence of THC.

Mr. Christman testified during the motions hearing. The military judge questioned him about the testing and forwarding of appellee’s urine sample:

MJ: Do you remember forwarding the drug sample in this case, in Sergeant Konieczka’s case?
WIT: Extremely well. I do recall this.
MJ: Well, what was your purpose in selecting and forwarding his sample?
WIT: It had 93.5 nanograms on my machine and I was very confident that that one would come back confirmed. I know that the laboratories confirm at 15 nanograms and so if it — I forwarded it thinking that if it got past the RIA (radioimmunoassay) at the forensic lab it indeed would be confirmed. I only put an “N” on a chain of custody because as long as it’s under the 100 on my machine I can’t call it positive and this is a normal — I do this in the regular course of business all the time.

At the time he authenticated the record, the military judge attached special findings. Although not recited here verbatim, the more significant of those are as follows:

1. That Mr. Christman, by forwarding appellee’s urine sample to Fort Meade for further testing, violated the provisions of Army Regulation (AR) 600-85, The Army Alcohol and Drug Abuse Prevention and Control Program, because the sample was not selected for that purpose on a random basis.
2. That Mr. Christman’s action in forwarding the appellee’s urine sample converted an inspection of the urine to a search because such action focused on an individual soldier and thus went beyond the scope of Mil.R.Evid. 313(b).
3. That such “search” was without probable cause and therefore prohibited by the fourth amendment of the United States Constitution.

II

Chapter 10, Army Reg. 600-85, Personnel — General: Alcohol and Drug Abuse Prevention and Control Program (21 Oct. 1988) [hereinafter AR 600-85], outlines the policy objectives for the United States Army biochemical testing program,1 the [754]*754purposes for which the tests may be administered,2 the types of testing programs, the responsibilities assigned for management and implementation of the programs, and the procedures to be used in taking the samples and testing them.

Urine or alcohol breath tests for active duty military personnel may be directed by a commander or a physician, or administered during the rehabilitation or treatment process. Specifically, AR 600-85 provides that a commander may direct a urinalysis of part or of the entire unit as an inspection. See AR 600-85, para. 10-3a. There is no indication in the record that the inspection which resulted in the taking of appellee’s urine sample was improperly ordered or conducted. Appellee concedes that the process, at least until after his sample was prescreened for the existence of drug metabolites, was in compliance with Manual for Courts-Martial, United States, 1984, Mil.R.Evid. [hereinafter Mil.R.Evid.] 313.3

The procedures for urine drug prescreening (field testing) are outlined in AR 600-85, para. 10-7, which provides that, although the primary means of testing drug specimens is through a Department of Defense certified laboratory (such as that which exists at Port Meade), installations may, through use of approved drug detection systems, make preliminary determinations regarding the absence or presence of drug metabolites in urine specimens. Mr. Christman testified that, after consultation with the Fort Lee installation commander, the decision was made to utilize this pres[755]*755creening procedure at Fort Lee to allow the commanders there to continue testing the same number of soldiers despite the reduction in the number of specimens they were authorized to send to the laboratory at Fort Meade. The key procedural provisions for the prescreening of urine samples are as follows:

1. “Negative” samples may be discarded unless they are submitted to the main laboratory for quality control purposes in accordance with Appendix F, AR 600-85.
2. “Positive” specimens must be immediately forwarded to the main laboratory for testing.
3. The prescreening must follow operational procedures as outlined in Appendix F, AR 600-85.
4. Urine specimens may be retested upon the request of the submitting installation or command.4

(Emphasis added). AR 600-85, Appendix F, Standard Operating Procedures for Installation Urine Drug Prescreening, provides guidance for operation of the equipment used in the prescreening process and outlines quality assurance procedures. Paragraph F-3a (4) states that between two and ten percent of prescreened negative specimens are to be forwarded to the main laboratory for testing as an internal quality control check. There is no requirement that the selections be made on a random basis. The purpose of forwarding negative samples is to insure that the urine prescreening is being properly conducted.

We thus conclude that Mr. Christman acted within his authority under the provisions of AR 600-85 in selecting appellee’s urine sample for forwarding to Fort Meade for testing. However, we must still determine whether Mr. Christman's decision to select appellee’s sample converted a legitimate inspection into an unauthorized search conducted in violation of the fourth amendment.

III

In examining this issue, we must look at three factors: the primary purpose of the inspection, the scope of the inspection process, and the reasonableness of the inspection in light of Mil.R.Evid.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Konieczka
31 M.J. 289 (United States Court of Military Appeals, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
30 M.J. 752, 1990 WL 35788, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-konieczka-usarmymilrev-1990.